Valeo Pharma Inc (VPH.TO)
0.105
0.00 (0.00%)
CAD |
TSX |
May 17, 16:00
Valeo Pharma Debt to Equity Ratio: -1.369 for Jan. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| January 31, 2024 | -1.369 |
| October 31, 2023 | -1.581 |
| July 31, 2023 | -1.751 |
| April 30, 2023 | -2.106 |
| January 31, 2023 | -2.565 |
| October 31, 2022 | -3.377 |
| July 31, 2022 | -8.220 |
| April 30, 2022 | -6.552 |
| January 31, 2022 | 35.68 |
| October 31, 2021 | 3.146 |
| July 31, 2021 | 0.9187 |
| Date | Value |
|---|---|
| April 30, 2021 | 5.887 |
| January 31, 2021 | 1.331 |
| October 31, 2020 | 0.9668 |
| July 31, 2020 | -1.935 |
| April 30, 2020 | -2.098 |
| January 31, 2020 | -2.282 |
| October 31, 2019 | -45.50 |
| July 31, 2019 | 0.0565 |
| April 30, 2019 | -0.9464 |
| January 31, 2019 | -1.180 |
| October 31, 2018 | -1.760 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-45.50
Minimum
Oct 2019
35.68
Maximum
Jan 2022
-1.650
Average
-1.751
Median
Jul 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 40.35M |
| Total Liabilities (Quarterly) | 87.37M |
| Shareholders Equity (Quarterly) | -47.01M |
| Current Ratio | 0.4855 |
| Net Debt Paydown Yield | -2.76% |